Medco SEC Filing For Spin-Off Included “False Statement” On Audit – DoJ Suit
Executive Summary
Medco's disclosure of record-keeping problems discovered at its Dallas/Fort Worth pharmacy in an SEC filing included a "false statement," the Philadelphia U.S. Attorney alleges in a complaint filed against the pharmacy benefit management company Sept. 29
You may also be interested in...
Merck Texas inquiry
Merck receives civil investigative demand from Texas attorney general seeking the "documents and other information regarding the company's marketing and selling activities relating to Texas," 1Merck's 10-K filing with SEC March 10 says. Record-keeping at Medco's Dallas/Fort Worth mail-order facility is the subject of an investigation by the Philadelphia U.S. Attorney's Office (2"The Pink Sheet" Oct. 6, 2003, p. 36). Medco was spun off by Merck in July...
Merck Texas inquiry
Merck receives civil investigative demand from Texas attorney general seeking the "documents and other information regarding the company's marketing and selling activities relating to Texas," 1Merck's 10-K filing with SEC March 10 says. Record-keeping at Medco's Dallas/Fort Worth mail-order facility is the subject of an investigation by the Philadelphia U.S. Attorney's Office (2"The Pink Sheet" Oct. 6, 2003, p. 36). Medco was spun off by Merck in July...
Abbott “Nominal Prices” Cited In Medco Suit; “Improper” Payments Alleged
Medco's access to "nominally priced" Abbott medicines is one example cited by the Philadelphia U.S. Attorney of an "inducement" accepted by the pharmacy benefit management company